NCT01780727

Brief Summary

Elderly patients are the fastest growing surgical population and have an increased risk of postoperative cardiac problems. Diastolic dysfunction, or the reduced ability of the heart' s ventricles to fill completely, is common in the elderly population and increases the risk of major adverse cardiac events after surgery. This study will measure diastolic filling and implement fluid and drug management during surgery to determine whether this reduces serious cardiac events related to diastolic dysfunction after surgery in this high-risk population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
97

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 23, 2013

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 31, 2013

Completed
1.6 years until next milestone

Study Start

First participant enrolled

September 1, 2014

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 27, 2018

Completed
Last Updated

September 15, 2023

Status Verified

September 1, 2023

Enrollment Period

3.7 years

First QC Date

January 23, 2013

Last Update Submit

September 13, 2023

Conditions

Keywords

echocardiographyhemodynamic management

Outcome Measures

Primary Outcomes (1)

  • Number of Patients who undergo dynamic heart function changes during surgery

    We will test the hypothesis that Left Ventricular Diastolic Dysfunction (LVDD) undergoes dynamic changes perioperatively. A. We will preoperatively identify 200 elderly subjects to provide 80% power to detect a change in LVDD undergoing noncardiac surgery using a 0.01 level two-sided paired t-test. B. We will assess changes in LVDD in these subjects based on hourly intraoperative echocardiography data points.

    2 years

Secondary Outcomes (1)

  • Safety of Echo-Guided Hemodynamic Management during surgery

    1 year

Study Arms (2)

Standard Hemodynamic Management (SHEM)

NO INTERVENTION

use of standard hemodynamic management

EGHEM

EXPERIMENTAL

use of echocardiography guided hemodynamic management to control fluid and drug therapy.

Procedure: EGHEM

Interventions

EGHEMPROCEDURE

Echocardiography guided hemodynamic management. Subjects in this arm will undergo intraoperative transesophageal echocardiography as part of the study.

EGHEM

Eligibility Criteria

Age70 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age 70 years and older
  • Echocardiographic Evidence of Grade I, II or III LVDD on Preoperative Transthoracic Echocardiography (TTE) examination
  • Undergoing Vascular Surgery including but not limited to : Lower extremity bypass,Open abdominal aortic aneurysm repair

You may not qualify if:

  • Patients with expected hospital stay \< 24 hours
  • Inability to undergo TEE and Transesophageal Echocardiography(TTE)
  • Clinical evidence/suspicion of elevated Intercranial Pressure (ICP)
  • Preoperative shock or systemic sepsis
  • Emergency operation
  • American Society of Anesthesiologists Status V
  • Participation in another clinical trial
  • General Anesthesia not planned for procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Nebraska Medical Center

Omaha, Nebraska, 68198, United States

Location

MeSH Terms

Conditions

Ventricular Dysfunction, LeftCardiovascular Diseases

Condition Hierarchy (Ancestors)

Ventricular DysfunctionHeart Diseases

Study Officials

  • Sasha K Shillcutt, MD

    UNMC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Arm 1 receives normal saline per the standard of care determined by the anesthesiologist. Arm 2 receives normal saline or furosemide per the results of the intraoperative echocardiogram.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 23, 2013

First Posted

January 31, 2013

Study Start

September 1, 2014

Primary Completion

May 31, 2018

Study Completion

August 27, 2018

Last Updated

September 15, 2023

Record last verified: 2023-09

Locations